A Phase 2, Randomised, Double-Blind, Placebo and Active Comparator-Controlled Study to Assess Efficacy and Safety of Mulitiple Dose Levels of AZD5718 Given Orally Once Daily for Twelve Weeks in Adults with Moderate-to-Severe Asthma

Project: Research

Project Details

Project Description

HREC Reference Number: HREC/85217/MonH-2023-367192(v3)
Monash Health Local Reference: RES-22-0000-250A
StatusActive
Effective start/end date3/05/23 → 2/05/28

Clinical Trial Phase

  • Phase II